ReviewCureus2026
Opioid Pain Medication Use in Athletes.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The use of opioids for pain management has become increasingly accepted over the years. There are known adverse effects of opioids that have implications for athletes when used for pain relief in the context of sports. Our objective was to conduct a review of the available literature to evaluate the following: (1) opioid use in athletes; (2) how to prevent initial use; (3) tapering opioids; and (4) nonopioid alternatives. A literature review was conducted on the prevalence of opioid use in athletes, strategies for preventing initial use and tapering opioids, and nonopioid alternatives for pain management in athletes. Use of opioids early in an athlete's career appears to increase the risk of subsequent use and misuse at college and professional levels. Prevention of initial use of opioids, establishing a timeline outlining the course and expectations for opioid use, and understanding the individual's level of sport and specific involvement are all important factors that can help prevent opioid misuse. More research is needed for clinicians to understand the level of use and misuse of narcotic pain medications in the athletic and active population. This issue should receive more consideration as the level of play increases. There are indications that opioid use has now become as prevalent in high school athletes as in higher levels of play, a trend that should be monitored and possibly curtailed in recognition of the greater risks in adolescents when it comes to narcotic pain medications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.